Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod IncfiledCriticalPfizer Prod Inc
Publication of UY25233A1publicationCriticalpatent/UY25233A1/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Plural Heterocyclic Compounds
(AREA)
Abstract
Composiciones terapéuticamente activas de materia y tipos de miembros de las mismas que comprenden compuestos que contienen indazol, resultando dichos compuestos y su actividad terapéutica directamente de una sustitución biosostérica de atecol por indazol de un compuesto que contienen catecol que tiene dicha actividad terapéutica, donde los substituyentes no catecol son los mismos u homólogos antes y después de dicha sustitución, en la que dichas composiciones de materia comprenden un compuesto de fórmula (I1)o (I2).Therapeutically active compositions of matter and types of members thereof comprising indazole-containing compounds, said compounds and their therapeutic activity resulting directly from a biososteric substitution of atecol for indazole of a catechol-containing compound having said therapeutic activity, where the substituents non-catechol are the same or homologous before and after said substitution, in which said compositions of matter comprise a compound of formula (I1) or (I2).
UY25233A1997-11-041998-11-04
BIOISOSTERIC SUBSTITUTION OF CATECOL BY INDAZOL IN THERAPEUTICALLY ACTIVE COMPOUNDS
UY25233A1
(en)
INDOL-3-GLIOXILAMIDAS N-SUBSTITUTED WITH ANTI-ASMATIC, ANTI-ALLERGIC AND IMMUNOSUPPRESSOR / IMMUNOMODULATOR EFFECTS, PROCEDURES FOR THEIR PREPARATION, PHARMACEUTICAL STRUCTURE AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
NEW TAXOIDS, PROCEDURE FOR PREPARING THEM, INTERMEDIATE APPLICATION COMPOUNDS WITH SUCH PROCEDURE, PROCEDURE FOR PREPARING SUCH INTERMEDIARIES AND PHARMACEUTICAL COMPOSITIONS CONTAINING SUCH TAXOIDS.